https://marketchameleon.com/articles/i/2026/10/20/31994-nflx-bearish-calendar-put-spread-is-inexpensive-at 2026-10-20T13:26:06.1322620-04:00 0.9 Market Chameleon en 2026-10-20T13:26:06.1322620-04:00 NFLX Bearish Calendar Put Spread is Inexpensive at 22 Cents NASDAQ:NFLX https://marketchameleon.com/articles/i/2026/10/20/31993-3-reasons-why-this-mrna-bull-put-spread-is-a-good- 2026-10-20T12:44:40.1373120-04:00 0.9 Market Chameleon en 2026-10-20T12:44:40.1373120-04:00 3 Reasons Why this MRNA Bull Put Spread is a Good Opportunity for $1.40 NASDAQ:MRNA https://marketchameleon.com/articles/b/2026/10/20/blte-nasdaq-global-select-market-uplisting-tinlarebant-stargardt 2026-10-20T11:59:54.2219400-04:00 0.9 Market Chameleon en 2026-10-20T11:59:54.2219400-04:00 Belite Bio moves up to Nasdaq’s top tier as it targets a potential first-ever Stargardt therapy $BLTE, #StockMovers https://marketchameleon.com/articles/b/2026/10/20/clfd-ceo-succession-plan-beranek-retirement-march-2027 2026-10-20T11:59:02.9444620-04:00 0.9 Market Chameleon en 2026-10-20T11:59:02.9444620-04:00 Clearfield sets CEO transition timeline with Beranek retiring March 31, 2027 $CLFD, #StockMovers https://marketchameleon.com/articles/b/2026/10/20/gm-cadillac-f1-frontieras-energy-transformation-partner 2026-10-20T11:58:12.4014030-04:00 0.9 Market Chameleon en 2026-10-20T11:58:12.4014030-04:00 GM Highlights Cadillac Formula 1 Team’s Multi-Year Energy Partnership as Shares Trade Lower Midday $GM, #StockMovers https://marketchameleon.com/articles/b/2026/10/20/htfl-november-12-2026-q3-earnings-date-ai-platform-adoption 2026-10-20T11:57:25.3908080-04:00 0.9 Market Chameleon en 2026-10-20T11:57:25.3908080-04:00 Heartflow Sets Nov. 12 Earnings Date as It Highlights 1,800+ Global Institutions Using Its AI Platform $HTFL, #StockMovers https://marketchameleon.com/articles/b/2026/10/20/clf-q3-2026-results-adjusted-ebitda-beats-guidance 2026-10-20T11:56:32.7597100-04:00 0.9 Market Chameleon en 2026-10-20T11:56:32.7597100-04:00 Cleveland-Cliffs posts its strongest quarter in three years as adjusted EBITDA beats prior guidance $CLF, #StockMovers https://marketchameleon.com/articles/b/2026/10/20/csqr-nov-9-2026-earnings-release-conference-call 2026-10-20T11:55:28.1629990-04:00 0.9 Market Chameleon en 2026-10-20T11:55:28.1629990-04:00 Csquare Sets Nov. 9 Earnings Date, Highlighting a Quarter Ended Sept. 30 $CSQR, #StockMovers https://marketchameleon.com/articles/b/2026/10/20/bill-ai-controls-risk-intelligence-suite-payment-mistakes 2026-10-20T11:54:43.0408040-04:00 0.9 Market Chameleon en 2026-10-20T11:54:43.0408040-04:00 BILL spotlights AI controls and risk intelligence after flagging ~$1.5B in payment mistakes $BILL, #StockMovers https://marketchameleon.com/articles/b/2026/10/20/bb-qnx-royalty-backlog-1-2b-alloy-kore-design-win 2026-10-20T11:53:44.0555110-04:00 0.9 Market Chameleon en 2026-10-20T11:53:44.0555110-04:00 BlackBerry highlights QNX royalty backlog topping $1.2B, led by a $100M+ Alloy Kore design win $BB, #StockMovers https://marketchameleon.com/articles/b/2026/10/20/hbcp-ceo-retirement-leadership-transition-2027-guidry-bordelon 2026-10-20T11:52:54.9950080-04:00 0.9 Market Chameleon en 2026-10-20T11:52:54.9950080-04:00 Home Bancorp names Darren Guidry as next CEO, with John Bordelon staying on as chairman through the 2027 transition $HBCP, #StockMovers https://marketchameleon.com/articles/b/2026/10/20/bull-shareholders-lead-plaintiff-deadline-december-7-2026-class-action 2026-10-20T11:52:07.5709890-04:00 0.9 Market Chameleon en 2026-10-20T11:52:07.5709890-04:00 BULL shareholders face a December 7, 2026 lead-plaintiff deadline after a House China report and securities-fraud allegations $BULL, #StockMovers https://marketchameleon.com/articles/b/2026/10/20/dmac-kol-webinar-nov-24-2026-phase-2-fgr-cohort-2-interim-results 2026-10-20T11:51:15.2958060-04:00 0.9 Market Chameleon en 2026-10-20T11:51:15.2958060-04:00 DiaMedica (DMAC) Sets Nov. 24 KOL Webinar to Add Interim Results From Two Phase 2 FGR Cohorts $DMAC, #StockMovers https://marketchameleon.com/articles/b/2026/10/20/ocs-predict-1-randomization-complete-licaminlimab-tnfr1-dry-eye 2026-10-20T11:50:20.6214250-04:00 0.9 Market Chameleon en 2026-10-20T11:50:20.6214250-04:00 Oculis finishes PREDICT-1 randomization with 176 patients, putting a genotype-guided dry eye readout on the 2026 calendar $OCS, #StockMovers https://marketchameleon.com/articles/b/2026/10/20/argx-alkivia-phase-3-tis-52-weeks-acr-convergence-2026-late-breaking 2026-10-20T11:49:23.2761600-04:00 0.9 Market Chameleon en 2026-10-20T11:49:23.2761600-04:00 argenx spotlights 15.4-point TIS advantage in ALKIVIA as ACR Convergence 2026 late-breaker $ARGX, #StockMovers https://marketchameleon.com/articles/b/2026/10/20/krmn-218-million-seven-year-thaad-shroud-agreement-lockheed-martin 2026-10-20T11:48:16.1742060-04:00 0.9 Market Chameleon en 2026-10-20T11:48:16.1742060-04:00 Karman wins a seven-year, $218 million THAAD shroud deal that boosts long-term production visibility $KRMN, #StockMovers